SARS-CoV-2 spike-protein targeted serology test results and their association with subsequent COVID-19-related outcomes
ImportanceIn the absence of evidence of clinical utility, the United States' Centers for Disease Control and Prevention does not currently recommend the assessment of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) spike-protein antibody levels. Clinicians and their patients, espec...
Saved in:
Main Authors: | Harvey W. Kaufman (Author), Stanley Letovsky (Author), William A. Meyer (Author), Laura Gillim (Author), Magdalene M. Assimon (Author), Carly A. Kabelac (Author), John W. Kroner (Author), Shannon L. Reynolds (Author), Marcia Eisenberg (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2023-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Spike protein of SARS-CoV-2 Omicron variant: An in-silico study evaluating spike interactions and immune evasion
by: Jose A. Jimenez Ruiz, et al.
Published: (2022) -
Potential antiviral peptides targeting the SARS-CoV-2 spike protein
by: Ibrahim Khater, et al.
Published: (2022) -
Assessment of the binding interactions of SARS-CoV-2 spike glycoprotein variants
by: Deepa Raghu, et al.
Published: (2022) -
Application of SARS-CoV-2 Serology to Address Public Health Priorities
by: Amy C. Sherman, et al.
Published: (2021) -
Histamine Potentiates SARS-CoV-2 Spike Protein Entry Into Endothelial Cells
by: Somasundaram Raghavan, et al.
Published: (2022)